All In Biotech

Drug Trial Radar · NCT06832410

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

A Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of VX-880 in Subjects With Type 1 Diabetes With a Kidney Transplant

Last checked: Nov 19, 2026Latest source record: Mar 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

10

Planned (sponsor's estimate)

Start

Mar 31, 2025

Primary completion

Sep 17, 2026

Study completion Sep 17, 2027

Sponsor

Lead sponsor
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
Sponsor type
Industry
First posted
Feb 18, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the efficacy, safety, and tolerability of VX-880 in participants with Type 1 Diabetes (TID) with a kidney transplant.

Conditions

  • Type 1 Diabetes
  • Kidney Transplant

Interventions

  • Biological/VaccineBiological

    Infused into the hepatic portal vein.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Participants who are Insulin IndependentTime frame: At 1 year After VX-880 infusion

Locations

7 sites in 3 countries. Site status is shown where the registry gives one.

  • Perelman Center for Advanced Medicine - Endocrinology

    Philadelphia, Pennsylvania · Recruiting

  • Montefiore Clinical and Translational Research Center - Endocrinology

    Pittsburgh, Pennsylvania · Recruiting

  • UW University Hospital - Endocrinology

    Madison, Wisconsin · Recruiting

  • Toronto General Hospital - Endocrinology

    Toronto, Canada · Recruiting

  • Vancouver General Hospital - Gordon and Leslie Diamond Health Care Centre

    Vancouver, Canada · Recruiting

  • King Abdullah International Medical Research Center (KAIMRC) - Riyadh - Endocrinology

    Riyadh, Saudi Arabia · Recruiting

  • King Faisal Specialist Hospital & Research Centre - Riyadh - Endocrinology

    Riyadh, Saudi Arabia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.